Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
Kidney Int Rep
.
2022 Aug 28;7(11):2546-2547.
doi: 10.1016/j.ekir.2022.08.016.
eCollection 2022 Nov.
Authors
Kevin Yau
1
2
,
Atit Dharia
1
2
,
Ibrahim Alrowiyti
1
2
,
David Z I Cherney
1
2
Affiliations
1
Department of Medicine, Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
2
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
PMID:
36531882
PMCID:
PMC9751670
DOI:
10.1016/j.ekir.2022.08.016
No abstract available